YOLT-203 for kidney calculi

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 May 2026: Trial registered, NCT07587021
  2. 16 Sep 2026: Trial started, NCT07587021

The trials

NCT07587021: Study of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1 (PH1)

State
Under way
Phase
Phase 2
People
36 planned
Started
16 Sep 2026
Primary completion
Aug 2027
Arms
YOLT-203
Results
None posted
  1. 14 May 2026: Trial registered
  2. 16 Sep 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Gene therapy.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.